David A Muller
11PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 28, 2026
Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults.Christopher L D McMillan, David A Muller, Germain J P Fernando
|Nov 25, 2023
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial.Ben Baker, Imogen M Bermingham, Indika Leelasena
|Jan 21, 2023
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern.Mahali S Morgan, Kexin Yan, Thuy T Le
|May 28, 2022
Absence of Anti-RBD Antibodies in SARS-CoV-2 Infected or Naive Individuals Prior to Vaccination with CoronaVac Leads to Short Protection of Only Four Months Duration.Camille F de Oliveira, Walter F F Neto, Carla P da Silva
|Apr 23, 2022
Local Response and Barrier Recovery in Elderly Skin Following the Application of High-Density Microarray Patches.Fredrik Iredahl, David A Muller, Totte Togö
|Apr 23, 2022
Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern.Christopher L D McMillan, Armira Azuar, Jovin J Y Choo
Pageof 2
Frequent Collaborators
6 joint publications
Naphak Modhiran
6 joint publications
Christopher L D McMillan
5 joint publications
Jody Hobson-Peters
5 joint publications
Germain J P Fernando
5 joint publications
Paul R Young
4 joint publications
Alberto A Amarilla
3 joint publications
Jovin J Y Choo
2 joint publications
Connor A P Scott
2 joint publications
Natalee D Newton
2 joint publications
Michael J Landsberg
